# Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma

> **NCT00556673** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 31 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** indacaterol maleate/mometasone furoate
- **DRUG:** placebo to indacaterol maleate/mometasone furoate
- **DRUG:** fluticasone proprionate / salmeterol xinafoate

## Key facts

- **NCT ID:** NCT00556673
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556673, "Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00556673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*